Mark T. Hegel, PhD
Professor of Psychiatry
Professor of Community and Family Medicine
Professor of The Dartmouth Institute
Community and Family Medicine
The Dartmouth Institute
Georgia State University, Atlanta, GA - PhD 1988
University of Hartford, West Hartford, CT - MA 1982
Assumption College, Worcester, MA - BS 1979
New Hampshire-Dartmouth Psychiatric Research Center
Department of Psychiatry
Dartmouth-Hitchcock Medical Center
Lebanon NH 03756
Behavioral health services in medical patients; Electronic tools for delivery of behavioral health interventions
Principal Investigator: NCI, â€œParticipation Restrictions in Young-Middle Adult Rural Breast Cancer Survivorsâ€ (R21CA140849) (4/1/10-3/31/12), $250,000 TDC.
Principal Investigator: Johnson & Johnson, Inc., â€œDevelopment and Evaluation of Enhanced HealthMediaÂ® OVERCOMINGâ„¢ Depression to Support Collaborative Depression Treatment in Primary Care: The RESPECT-D-E (Enhanced) Trialâ€ (4/1/10-3/31/13), $689,214 TDC.
Co-Investigator: NINR â€œEarly vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effectsâ€(R01NR011871-01). PI:Marie Bakitas, Dartmouth Medical School (10/1/09-9/30/12).
Consultant: NIMH, â€œTelehealth Problem Solving Therapy for Depressed Homebound Adultsâ€ (R34) PI: Namkee Choi, University of Texas at Austin (4/1/09-3/31/11).
Consultant: NIA, â€œImproving Care Planning and Well-being in Older Adults with Macular Degenerationâ€ (R01AG00280422). PI: Silvia Sorensen, University of Rochester (7/09-6/14) $1,827,976 TDC
Consultant: NIMH, â€œTreating Subthreshold Depression in Geriatric Vision Rehabilitationâ€(R34MH079980). PI: Amy Horowitz, Mt Sinai School of Medicine (9/1/09-8/31/11)
Principal Investigator: Cancer and Leukemia Group B Foundation, â€œFeasibility of a Phone-Delivered Behavioral Activation/Problem Solving Intervention to Enhance Role Function Recovery and QOL in â€˜At-Riskâ€™ Breast Cancer Patients Following Cancer Treatmentâ€ (70804) (2008-2010), $25,000 TDC.
Co-Investigator: NEI, â€œLow Vision Depression Prevention Trial for Age Related Macular Degenerationâ€ (U01 EY018819-01). PI: Barry Rovner, Thomas Jefferson University (1/1/09-12/31/13).
Principal Investigator: NCI, â€œPreserving Function in Rural Breast Cancer Patients Undergoing Chemotherapyâ€ (1R03CA124200-01) (9/1/06 â€“ 8/31/08).
Principal Investigator: NCI, â€œImproving Palliative Care for Patients with Cancerâ€ (R01CA101704) (4/1/06-6/30/08).
Co-Investigator: NCI, â€œCancer Patientsâ€™ Assessments Regarding Excellence (CARE)â€. PI: Joan Teno, Brown University (4/1/06-6/30/07).
Co-Investigator: Robert Wood Johnson Foundation Physician Faculty Program, "Managing Depression in Mothers of Head Start Preschoolers". PI: Michael Silverstein, Boston University (1/06-12/10).
Co-Investigator: NEI, â€œImproving Function in Age Related Macular Degenerationâ€; PI: Barry Rovner, Thomas Jefferson University (10/05-9/10).
Co-Investigator: NSBRI, â€œDevelopment of a Smart Medical System for Psychosocial Support During Long Duration Space Flightâ€; PI: James Carter, Harvard Medical School (1/05-12/07).
Family Practice Clerkship Facilitator (DMS III and IV)
Health, Society and the Physician (DMS IV)
The role of a palliative care intervention in moderating the relationship between depression and survival among individuals with advanced cancer.
Content Analysis of a Participant-Directed Intervention to Optimize Activity Engagement of Older Adult Cancer Survivors.
Weight Bias Education for Medical School Faculty: Workshop and Assessment.
Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
Randomized Controlled Trial of a Computerized Interactive Media-Based Problem Solving Treatment for Depression.
Uncontrolled pilot study of an Acceptance and Commitment Therapy and Health at Every Size intervention for obese, depressed women: Accept Yourself!
Autonomous, Computer-Based Behavioral Health Countermeasure Evaluation at HI-SEAS Mars Analog.
Depression in Visual Impairment Trial (DEPVIT): A Randomized Clinical Trial of Depression Treatments in People With Low Vision.
Cognitive and Affective Representations of Active Surveillance as a Treatment Option for Low-Risk Prostate Cancer.
High Prevalence of Untreated Depression in Patients Accessing Low-Vision Services.